November 4, 2020
9:00am PT/12:00pm ET
Management of CMV: What’s New, What’s Innovative, What Does the Future Hold?
Alissa Wright, MD (Vancouver General Hospital, St Paul’s Hospital, Vancouver Coastal Health, Vancouver, BC)
Jean-Sébastien Delisle, MD, FRCPC, PhD (Hôpital Maisonneuve-Rosemont, Montreal, Québec)
Donald Vinh, MD, FRCPC, FACP (Department of Medicine, Faculty of Medicine, McGill University, Montreal, Québec)
Review and evaluate new approaches on the management of CMV
This webinar is sponsored by
We have updated our webinar registration process. After completing your registration on our website you will be asked to finalize your registration with GoToWebinar to receive a confirmation email containing all of the information about joining the webinar.
For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.